Mapping neuropeptide-controlled reward circuits in the brain
Isolation of brain reward circuits using peptidergic systems
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-11307598
This work looks at how neuropeptides and specific ion channels shape dopamine cells in the brain's reward center to inform future treatments for addiction and mood problems.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11307598 on ClinicalTrials.gov |
What this research studies
From a patient's perspective, researchers are reading the gene signatures of different dopamine-producing cells in the ventral tegmental area to find what makes each subtype unique. They use single-nucleus RNA sequencing, genetic tools (including CRISPR-based methods), circuit-mapping techniques, and drugs to test how specific ion channels and a neuropeptide receptor change cell firing and connectivity. The team also activates the receptor-defined cells to see how those neurons influence behavior in model systems. Findings aim to link molecular identity, electrical properties, and wiring to how reward-related brain circuits work.
Who could benefit from this research
Good fit: People with disorders of reward processing such as addiction or mood disorders would be the likely candidates for follow-on clinical work informed by these findings, though the current project is mainly lab-based.
Not a fit: Patients with conditions unrelated to dopamine or reward circuitry, or those seeking immediate treatments, are unlikely to receive direct benefit from this basic research now.
Why it matters
Potential benefit: If successful, this could point to much more targeted therapies that act on specific dopamine cell types to better treat addiction, depression, and other reward-related disorders.
How similar studies have performed: Previous molecular and electrophysiology studies have identified dopamine neuron diversity and some ion-channel roles, but translating detailed molecular maps into therapies remains largely untested.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZWEIFEL, LARRY S — UNIVERSITY OF WASHINGTON
- Study coordinator: ZWEIFEL, LARRY S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.